Methylphenidate
Narcolepsy, Attention Deficit Hyperactivity Disorder
Treatment
20 Active Studies for Methylphenidate
Treatment for
Narcolepsy
What is Methylphenidate
Methylphenidate
The Generic name of this drug
Treatment Summary
Methylphenidate is a medication used to treat Attention Deficit/Hyperactivity Disorder (ADHD) and narcolepsy. It is sold under the brand names Ritalin, Concerta, and Biphentin. Methylphenidate works by increasing the activity of certain brain chemicals, like dopamine and norepinephrine, which help to improve focus and attention. The effects of methylphenidate last up to 10-12 hours, so it can be taken once a day. However, methylphenidate has the potential to be abused and can cause addiction, so it is important to take it as prescribed by your doctor
Methylphenidate Hydrochloride
is the brand name
Methylphenidate Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Methylphenidate Hydrochloride
Methylphenidate
1955
490
Effectiveness
How Methylphenidate Affects Patients
Methylphenidate is a combination of two different isomers (d- and l-). The d-isomer is the active part of the drug, and binds to dopamine-rich areas of the brain, especially in the prefrontal cortex. This area is thought to be important in attention-deficit / hyperactivity disorder (ADHD). In animal studies, this drug has been shown to increase movement activity and cause repetitive behaviors.
How Methylphenidate works in the body
Methylphenidate helps people with ADHD by increasing the activity of two neurotransmitters, norepinephrine and dopamine, in the brain. Low doses of methylphenidate work to reduce impulsivity and improve cognitive functions like attention and memory. It also has an effect on alpha-1 adrenergic receptors, which helps with sustained attention. People with ADHD may have genetic abnormalities that affect the dopamine transporter gene, D4 receptor gene, and D2 receptor gene. Methylphenidate can help to overcome these genetic issues by increasing dopamine activity in the brain.
When to interrupt dosage
The amount of Methylphenidate is reliant upon the diagnosed situation. The dosage quantity may differ depending upon the technique of delivery featured in the table beneath.
Condition
Dosage
Administration
Attention Deficit Hyperactivity Disorder
20.0 mg, , 30.0 mg, 40.0 mg, 10.0 mg, 60.0 mg, 27.0 mg, 36.0 mg, 54.0 mg, 50.0 mg, 5.0 mg, 2.5 mg, 5.0 mg/mL, 10.0 mg/mL, 18.0 mg, 80.0 mg, 15.0 mg, 10.0 mg/hour, 20.0 mg/hour, 15.0 mg/hour, 30.0 mg/hour, 30.0 mg/mL, 6.0 mg/mL, 7.5 mg/mL, 9.0 mg/mL, 8.6 mg, 25.9 mg, 17.3 mg, 1.0 mg/mL, 2.0 mg/mL, 25.0 mg, 35.0 mg, 55.0 mg, 70.0 mg, 85.0 mg, 100.0 mg, 45.0 mg, 72.0 mg, 63.0 mg
, Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet - Oral, Capsule, Capsule - Oral, Tablet, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, chewable - Oral, Solution, Solution - Oral, Tablet, chewable, Tablet, extended release, Tablet, extended release - Oral, Transdermal, Patch - Transdermal, Patch, Suspension, extended release - Oral, Suspension, extended release, Tablet, Chewable, Extended Release, Tablet, Chewable, Extended Release - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral
Narcolepsy
20.0 mg, , 30.0 mg, 40.0 mg, 10.0 mg, 60.0 mg, 27.0 mg, 36.0 mg, 54.0 mg, 50.0 mg, 5.0 mg, 2.5 mg, 5.0 mg/mL, 10.0 mg/mL, 18.0 mg, 80.0 mg, 15.0 mg, 10.0 mg/hour, 20.0 mg/hour, 15.0 mg/hour, 30.0 mg/hour, 30.0 mg/mL, 6.0 mg/mL, 7.5 mg/mL, 9.0 mg/mL, 8.6 mg, 25.9 mg, 17.3 mg, 1.0 mg/mL, 2.0 mg/mL, 25.0 mg, 35.0 mg, 55.0 mg, 70.0 mg, 85.0 mg, 100.0 mg, 45.0 mg, 72.0 mg, 63.0 mg
, Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet - Oral, Capsule, Capsule - Oral, Tablet, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, chewable - Oral, Solution, Solution - Oral, Tablet, chewable, Tablet, extended release, Tablet, extended release - Oral, Transdermal, Patch - Transdermal, Patch, Suspension, extended release - Oral, Suspension, extended release, Tablet, Chewable, Extended Release, Tablet, Chewable, Extended Release - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral
Warnings
Methylphenidate Contraindications
Condition
Risk Level
Notes
advanced arteriosclerosis
Do Not Combine
Gilles de la Tourette syndrome
Do Not Combine
Thyrotoxicosis
Do Not Combine
Pulse Frequency
Do Not Combine
Open-angle glaucoma
Do Not Combine
Hypertensive disease
Do Not Combine
Pulse Frequency
Do Not Combine
Tension-Type Headache
Do Not Combine
Generalized Anxiety Disorder
Do Not Combine
symptomatic cardiovascular disease
Do Not Combine
Tourette Syndrome
Do Not Combine
Pheochromocytoma
Do Not Combine
Tics
Do Not Combine
Agitation
Do Not Combine
There are 20 known major drug interactions with Methylphenidate.
Common Methylphenidate Drug Interactions
Drug Name
Risk Level
Description
Desflurane
Major
Methylphenidate may increase the hypertensive activities of Desflurane.
Diethyl ether
Major
Methylphenidate may increase the hypertensive activities of Diethyl ether.
Enflurane
Major
Methylphenidate may increase the hypertensive activities of Enflurane.
Halothane
Major
Methylphenidate may increase the hypertensive activities of Halothane.
Isoflurane
Major
Methylphenidate may increase the hypertensive activities of Isoflurane.
Methylphenidate Toxicity & Overdose Risk
Overdosing on morphine can cause vomiting, restlessness, tremors, overactive reflexes, muscle spasms, seizures (sometimes followed by a coma), feeling happy and excited, confusion, seeing or hearing things that aren't real, delirium, sweating, redness of the face, headaches, high body temperature, rapid heartbeat, heart rhythm problems, high blood pressure, wide pupils, and dryness of the mouth. The lowest toxic dose for mice is 190mg/kg when given orally.
Methylphenidate Novel Uses: Which Conditions Have a Clinical Trial Featuring Methylphenidate?
84 active studies are presently assessing the potential of Methylphenidate to provide relief for Attention Deficit Hyperactivity Disorder.
Condition
Clinical Trials
Trial Phases
Attention Deficit Hyperactivity Disorder
61 Actively Recruiting
Not Applicable, Phase 3, Phase 4, Phase 1, Phase 2
Narcolepsy
2 Actively Recruiting
Not Applicable, Phase 1
Methylphenidate Reviews: What are patients saying about Methylphenidate?
5
Patient Review
9/8/2015
Methylphenidate for Attention Deficit Disorder with Hyperactivity
5
Patient Review
4/8/2019
Methylphenidate for Attention Deficit Disorder with Hyperactivity
5
Patient Review
5/31/2019
Methylphenidate for Attention Deficit Disorder with Hyperactivity
5
Patient Review
9/8/2015
Methylphenidate for Attention Deficit Disorder with Hyperactivity
5
Patient Review
4/8/2019
Methylphenidate for Attention Deficit Disorder with Hyperactivity
5
Patient Review
5/31/2019
Methylphenidate for Attention Deficit Disorder with Hyperactivity
4.7
Patient Review
10/14/2021
Methylphenidate for Attention Deficit Disorder with Hyperactivity
4.7
Patient Review
7/12/2021
Methylphenidate for Recurring Sleep Episodes During the Day
4.7
Patient Review
10/14/2021
Methylphenidate for Attention Deficit Disorder with Hyperactivity
4.7
Patient Review
7/12/2021
Methylphenidate for Recurring Sleep Episodes During the Day
4.3
Patient Review
5/27/2016
Methylphenidate for Recurring Sleep Episodes During the Day
4.3
Patient Review
4/14/2018
Methylphenidate for Attention Deficit Disorder with Hyperactivity
4.3
Patient Review
5/27/2016
Methylphenidate for Recurring Sleep Episodes During the Day
4.3
Patient Review
4/14/2018
Methylphenidate for Attention Deficit Disorder with Hyperactivity
4
Patient Review
10/20/2016
Methylphenidate for Attention Deficit Disorder with Hyperactivity
4
Patient Review
10/20/2016
Methylphenidate for Attention Deficit Disorder with Hyperactivity
4
Patient Review
1/18/2020
Methylphenidate for Cognitive Impairment following Traumatic Brain Injury
4
Patient Review
1/18/2020
Methylphenidate for Cognitive Impairment following Traumatic Brain Injury
3.7
Patient Review
1/14/2016
Methylphenidate for Attention Deficit Disorder with Hyperactivity
3.7
Patient Review
3/30/2021
Methylphenidate for Depression
3.7
Patient Review
1/14/2016
Methylphenidate for Attention Deficit Disorder with Hyperactivity
3.7
Patient Review
3/30/2021
Methylphenidate for Depression
3.3
Patient Review
6/18/2019
Methylphenidate for Attention Deficit Disorder with Hyperactivity
3.3
Patient Review
6/18/2019
Methylphenidate for Attention Deficit Disorder with Hyperactivity
3
Patient Review
3/17/2021
Methylphenidate for Attention Deficit Disorder with Hyperactivity
3
Patient Review
3/17/2021
Methylphenidate for Attention Deficit Disorder with Hyperactivity
2
Patient Review
10/24/2017
Methylphenidate for Attention Deficit Disorder with Hyperactivity
2
Patient Review
4/7/2016
Methylphenidate for Attention Deficit Disorder with Hyperactivity
2
Patient Review
10/24/2017
Methylphenidate for Attention Deficit Disorder with Hyperactivity
2
Patient Review
4/7/2016
Methylphenidate for Attention Deficit Disorder with Hyperactivity
1.3
Patient Review
9/29/2017
Methylphenidate for Attention Deficit Disorder with Hyperactivity
1.3
Patient Review
9/29/2017
Methylphenidate for Attention Deficit Disorder with Hyperactivity
Patient Q&A Section about methylphenidate
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What will methylphenidate do to a normal person?
"Do not drive after taking methylphenidate until you know how the medicine affects you, as it may cause dizziness, drowsiness, or changes in vision. Methylphenidate may also cause serious heart or blood vessel problems, which are more likely in patients with a family history of heart disease."
Answered by AI
Is methylphenidate a serious drug?
"Methylphenidate should only be used as prescribed by a doctor to avoid any serious health problems, including heart and blood pressure problems that could potentially be fatal. This medication has a risk of being habit-forming, so it should be used with caution by people who have mental/mood disorders or a substance use disorder."
Answered by AI
Is methylphenidate the same as Adderall?
"Adderall is the brand name for a mix of two stimulants called amphetamine-dextroamphetamine. Ritalin is the brand name for a stimulant called methylphenidate."
Answered by AI
Is methylphenidate a stimulant?
"Heres a rundown of how these drugs work:
These drugs work by increasing levels of the neurotransmitters dopamine and norepinephrine in the brain. This can help to improve focus, concentration, and task completion.
Stimulant medications that increase levels of dopamine and norepinephrine in the brain are often prescribed to treat children, adolescents, or adults diagnosed with attention-deficit hyperactivity disorder (ADHD). These drugs can help improve focus, concentration, and task completion."
Answered by AI